Novo Nordisk's pipeline drugs show 'astonishing' weight-loss effects – but can it convince sceptical payers that medicines are the answer to the obesity epidemic?
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.